RIPK1 inhibition attenuates experimental autoimmune arthritis via suppression of osteoclastogenesis

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1479-5876

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: RIPK1 inhibition attenuates experimental autoimmune arthritis via suppression of osteoclastogenesis ; volume:17 ; number:1 ; day:15 ; month:3 ; year:2019 ; pages:1-9 ; date:12.2019
Journal of translational medicine ; 17, Heft 1 (15.3.2019), 1-9, 12.2019

Creator: Jhun, Jooyeon
Lee, Seung Hoon
Kim, Se-Young
Ryu, Jaeyoon
Kwon, Ji Ye
Na, Hyun Sik
Jung, KyoungAh
Moon, Su-Jin
Cho, Mi-La
Min, Jun-Ki

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12967-019-1809-3

URN: urn:nbn:de:101:1-2019040719594513572510

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:45 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Jhun, Jooyeon
Lee, Seung Hoon
Kim, Se-Young
Ryu, Jaeyoon
Kwon, Ji Ye
Na, Hyun Sik
Jung, KyoungAh
Moon, Su-Jin
Cho, Mi-La
Min, Jun-Ki
SpringerLink (Online service)

Other Objects (12)

Ginsenoside compound-K attenuates OVX-induced osteoporosis via the suppression of RANKL-induced osteoclastogenesis and oxidative stress

Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway

NLRC3 attenuates osteoclastogenesis by limiting TNFα+ Th17 cell response in osteoporosis

EC-18 prevents autoimmune arthritis by suppressing inflammatory cytokines and osteoclastogenesis

Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathways

Sigma‐1 receptor attenuates osteoclastogenesis by promoting ER‐associated degradation of SERCA2

MicroRNA-24-3p Attenuates Myocardial Ischemia/Reperfusion Injury by Suppressing RIPK1 Expression in Mice

R‐flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice

Metformin attenuates lung fibrosis development via NOX4 suppression

Antibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN)

IL‐33 attenuates the development of experimental autoimmune uveitis

Endothelial cell‐derived oxysterol ablation attenuates experimental autoimmune encephalomyelitis

Ginsenoside compound-K attenuates OVX-induced osteoporosis via the suppression of RANKL-induced osteoclastogenesis and oxidative stress

Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway

NLRC3 attenuates osteoclastogenesis by limiting TNFα+ Th17 cell response in osteoporosis

EC-18 prevents autoimmune arthritis by suppressing inflammatory cytokines and osteoclastogenesis

Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathways

Sigma‐1 receptor attenuates osteoclastogenesis by promoting ER‐associated degradation of SERCA2

MicroRNA-24-3p Attenuates Myocardial Ischemia/Reperfusion Injury by Suppressing RIPK1 Expression in Mice

R‐flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice

Metformin attenuates lung fibrosis development via NOX4 suppression

Antibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN)

IL‐33 attenuates the development of experimental autoimmune uveitis

Endothelial cell‐derived oxysterol ablation attenuates experimental autoimmune encephalomyelitis

Ginsenoside compound-K attenuates OVX-induced osteoporosis via the suppression of RANKL-induced osteoclastogenesis and oxidative stress

Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway

NLRC3 attenuates osteoclastogenesis by limiting TNFα+ Th17 cell response in osteoporosis

EC-18 prevents autoimmune arthritis by suppressing inflammatory cytokines and osteoclastogenesis

Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathways

Sigma‐1 receptor attenuates osteoclastogenesis by promoting ER‐associated degradation of SERCA2

MicroRNA-24-3p Attenuates Myocardial Ischemia/Reperfusion Injury by Suppressing RIPK1 Expression in Mice

R‐flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice

Metformin attenuates lung fibrosis development via NOX4 suppression

Antibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN)

IL‐33 attenuates the development of experimental autoimmune uveitis

Endothelial cell‐derived oxysterol ablation attenuates experimental autoimmune encephalomyelitis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

RIPK1 inhibition attenuates experimental autoimmune arthritis via suppression of osteoclastogenesis

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Ginsenoside compound-K attenuates OVX-induced osteoporosis via the suppression of RANKL-induced osteoclastogenesis and oxidative stress

Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway

NLRC3 attenuates osteoclastogenesis by limiting TNFα+ Th17 cell response in osteoporosis

EC-18 prevents autoimmune arthritis by suppressing inflammatory cytokines and osteoclastogenesis

Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathways

Sigma‐1 receptor attenuates osteoclastogenesis by promoting ER‐associated degradation of SERCA2

MicroRNA-24-3p Attenuates Myocardial Ischemia/Reperfusion Injury by Suppressing RIPK1 Expression in Mice

R‐flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice

Metformin attenuates lung fibrosis development via NOX4 suppression

Antibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN)

IL‐33 attenuates the development of experimental autoimmune uveitis

Endothelial cell‐derived oxysterol ablation attenuates experimental autoimmune encephalomyelitis

Ginsenoside compound-K attenuates OVX-induced osteoporosis via the suppression of RANKL-induced osteoclastogenesis and oxidative stress

Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway

NLRC3 attenuates osteoclastogenesis by limiting TNFα+ Th17 cell response in osteoporosis

EC-18 prevents autoimmune arthritis by suppressing inflammatory cytokines and osteoclastogenesis

Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathways

Sigma‐1 receptor attenuates osteoclastogenesis by promoting ER‐associated degradation of SERCA2

MicroRNA-24-3p Attenuates Myocardial Ischemia/Reperfusion Injury by Suppressing RIPK1 Expression in Mice

R‐flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice

Metformin attenuates lung fibrosis development via NOX4 suppression

Antibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN)

IL‐33 attenuates the development of experimental autoimmune uveitis

Endothelial cell‐derived oxysterol ablation attenuates experimental autoimmune encephalomyelitis

Ginsenoside compound-K attenuates OVX-induced osteoporosis via the suppression of RANKL-induced osteoclastogenesis and oxidative stress

Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway

NLRC3 attenuates osteoclastogenesis by limiting TNFα+ Th17 cell response in osteoporosis

EC-18 prevents autoimmune arthritis by suppressing inflammatory cytokines and osteoclastogenesis

Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathways

Sigma‐1 receptor attenuates osteoclastogenesis by promoting ER‐associated degradation of SERCA2

MicroRNA-24-3p Attenuates Myocardial Ischemia/Reperfusion Injury by Suppressing RIPK1 Expression in Mice

R‐flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice

Metformin attenuates lung fibrosis development via NOX4 suppression

Antibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN)

IL‐33 attenuates the development of experimental autoimmune uveitis

Endothelial cell‐derived oxysterol ablation attenuates experimental autoimmune encephalomyelitis

Related objects

Reset password